CAMBRIDGE, Mass., Apr 11, 2007 (BUSINESS WIRE) -- Curis, Inc. (NASDAQ: CRIS), a drug development company focused on novel targeted medicines primarily for cancer treatment, today announced that the company will be presenting at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference, being held April 11th and 12th. The company's presentation will take place on Wednesday, April 11th, at 11:30 a.m. in Room 3.05, with a 30-minute breakout session immediately following in Room 3.06 at the Millennium Broadway Hotel in New York City.
Daniel Passeri, Curis' President and CEO, will provide an overview of the status of the company's business and collaborations. There will also be a corresponding webcast of the presentation, which can be accessed by visiting: http://www.veracast.com/webcasts/cibcwm/biotech07/23107134.cfm
The presentation will be archived shortly after the live event and available for 90 days following the conference. In addition, it will also be available for 30 days on the Investor Relations section of the Curis website at www.curis.com.
About Curis, Inc.
Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to create new medicines, primarily for cancer. In expanding its drug development efforts in the field of cancer through its Targeted Cancer Drug Development Platform, the Company is building upon its previous experiences in targeting signaling pathways in the areas of cancer, neurological disease, hair growth regulation and cardiovascular disease. For more information, visit www.curis.com.
SOURCE: Curis, Inc.
Curis, Inc.
Michael P. Gray, 617-503-6632
Chief Financial Officer
mgray@curis.com
or
For Curis, Inc.
Jenny Viscarolasaga, 617-503-6658
Jenny@tworoadscommunications.com